Calgary Mind & Wellness Clinic on Facebook

Sep 10, 2026EXOMIND & rTMS Research0 comments

EXOMIND & rTMS Calgary

rTMS vs Medication for Treatment-Resistant Depression

When depression has not improved enough, the decision is rarely as simple as choosing a device instead of a pill. rTMS and medication differ in how they are delivered, their side-effect patterns and the evidence supporting them.

Book a Free 15-Minute EXOMIND Consultation

Clinician-led screeningNon-invasive treatmentPersonalized care plan

Why this matters

Quick answer: rTMS is a non-invasive, clinic-based treatment that targets brain networks using magnetic pulses. Medication affects the body systemically. Either may be used alone or as part of a broader plan.

Research Spotlight

Different tools, shared decision

  • Non-invasive option
  • Different side-effect profile
  • Evidence varies by protocol
  • Individual choice matters

How the options differ

rTMS

Treatment occurs through repeated clinic visits. It does not require anaesthesia and generally has limited systemic side effects. Common effects include temporary scalp discomfort or headache. Access, time commitment and protocol fit are practical considerations.

Medication

Medication is usually taken at home and can be effective and easier to integrate into a daily schedule. Side effects vary by medicine and person and can include sleep, digestive, sexual or weight-related effects. Medication changes require prescriber oversight.

What does the evidence say?

Meta-analytic evidence supports rTMS as an option for treatment-resistant major depression, but response is not guaranteed and estimates vary across protocols and study populations. A 2023 systematic review found active rTMS more effective than sham treatment across several commonly used protocols.

A better decision framework

  • Review which treatments were tried, at what dose and for how long.
  • Consider urgency, safety, side effects and practical access.
  • Agree on symptom and function measures before treatment.
  • Plan a review point and alternatives if progress is limited.

Research source

2023 systematic review and meta-analysis of rTMS for treatment-resistant depression.

Clinical note: This educational article does not diagnose a condition or replace individualized medical or psychological advice. Suitability depends on a clinician-led assessment.

Compare options with a clinician

A consultation can help organize your treatment history and determine whether EXOMIND rTMS deserves consideration.

Book a ConsultationExplore the related Calgary service

Reviewed by Dr. Courtney Dookie, Calgary Mind & Wellness Clinic.